PT - JOURNAL ARTICLE AU - Hiren Banerjee AU - Barbara Knoblach AU - Richard A Rachubinski TI - The early-acting glycosome biogenic protein Pex3 is essential for trypanosome viability AID - 10.26508/lsa.201900421 DP - 2019 Aug 01 TA - Life Science Alliance PG - e201900421 VI - 2 IP - 4 4099 - https://www.life-science-alliance.org/content/2/4/e201900421.short 4100 - https://www.life-science-alliance.org/content/2/4/e201900421.full SO - Life Sci. Alliance2019 Aug 01; 2 AB - Trypanosomatid parasites are infectious agents for diseases such as African sleeping sickness, Chagas disease, and leishmaniasis that threaten millions of people, mostly in the emerging world. Trypanosomes compartmentalize glycolytic enzymes to an organelle called the glycosome, a specialized peroxisome. Functionally intact glycosomes are essential for trypanosomatid viability, making glycosomal proteins as potential drug targets against trypanosomatid diseases. Peroxins (Pex), of which Pex3 is the master regulator, control glycosome biogenesis. Although Pex3 has been found throughout the eukaryota, its identity has remained stubbornly elusive in trypanosomes. We used bioinformatics predictive of protein secondary structure to identify trypanosomal Pex3. Microscopic and biochemical analyses showed trypanosomal Pex3 to be glycosomal. Interaction of Pex3 with the peroxisomal membrane protein receptor Pex19 observed for other eukaryotes is replicated by trypanosomal Pex3 and Pex19. Depletion of Pex3 leads to mislocalization of glycosomal proteins to the cytosol, reduced glycosome numbers, and trypanosomatid death. Our findings are consistent with Pex3 being an essential gene in trypanosomes.